ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Clark Wins Sheen award; Research Training Cuts Prompt PhD Holders To Apply Medical Schools

July 12, 1974

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

Congress Signals Willingness to Break With Administration on NIH Funding.

March 24, 2006

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981